Riwei Yang

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

First Affiliated Hospital of Guangzhou Medical University(Current)

Guangzhou Medical University

Riwei Yang is an author at First Affiliated Hospital of Guangzhou Medical University specializing in cancer immunotherapy, oncology, and immunotherapy.

ORCID

Publications per year

2022–2023

Publications

Fc Fragment of <scp>IgE</scp> Receptor Ig (<scp>FCER1G</scp>) acts as a key gene involved in cancer immune infiltration and tumour microenvironment

Riwei Yang, Zude Chen, Leqi Liang et al. · Immunology · 2022 · 27 citations

Medicine, Immunology, Oncology +17

Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients

Zhenglin Chang, Rongqi Li, Jinhu Zhang et al. · Frontiers in Immunology · 2022 · 16 citations · Full text

Medicine, Immunology, Oncology +17

A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy

Zude Chen, Xiaoshuang Yang, Zugen Chen et al. · BMC Medicine · 2023 · 16 citations · Full text

Medicine, Cancer Biology, Oncology +17

COVID-19 inhibits spermatogenesis in the testes by inducing cellular senescence

Zuomin Wang, Yuxiang Ma, Zude Chen et al. · Frontiers in Genetics · 2023 · 11 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

1–4 of 4